Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample

International Journal of Geriatric Psychiatry

Volumn 22, Issue 8, 2007, Pages 801-805

  Marcus, Jacqueline F ^a   Cellar, Janet S ^a   Ansari, Farzaneh Pour ^a   Bliwise, Donald L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Algase Wandering Scale; Alzheimer's disease; Restless legs syndrome; Wandering

Indexed keywords

ANTIDEPRESSANT AGENT; DONEPEZIL; GALANTAMINE; MEMANTINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FALLING; FEMALE; FUNCTIONAL STATUS; HUMAN; MALE; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; OUTPATIENT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; SYMPTOM; VALIDATION PROCESS; WANDERING BEHAVIOR;

ACCIDENTAL FALLS; ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; CAREGIVERS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GEORGIA; HUMANS; MALE; MENTAL DISORDERS; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; ORIENTATION; PSYCHOMETRICS; RISK FACTORS; WOUNDS AND INJURIES;

EID: 34548293177     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1745     Document Type: Article

References (37)

1. Agargun MY, Kara H, Ozbek H, et al. 2002. Restless legs syndrome induced by mirtazapine. J Clin Psychiatry 63: 1179.
2. Algase DL. 1999. Wandering in Dementia. Annu Rev Nurs Res 17: 185-217.
3. Algase DL, Beattie ER, Bogue EL, Yao L. 2001. The Algase Wandering Scale: initial psychometrics of a new caregiver reporting tool. Am J Alzheimers Dis Other Demen 16: 141-152.
4. Algase DL, Beattie ER, Leitsch SA, Beel-Bates CA. 2003. Biomechanical activity devices to index wandering behavior in dementia. Am J Alzheimers Dis Other Demen 18: 85-92.
5. Algase DL, Son GR, Beattie E, et al. 2004a. The interrelatedness of wandering and wayfinding in a community sample of persons with dementia. Dement Geriatr Cogn Disord 17: 231-239.
6. Algase DL, Beattie ER, Song JA, et al. 2004b. Validation of the Algase Wandering Scale (Version 2) in a cross cultural sample. Aging Ment Health 8: 133-142.
7. Allen RP, Picchietti D, Hening WA, et al. 2003. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101-119.
8. Bliwise DL, Carroll JS, Lee KA, et al. 1993. Sleep and 'sundowning' in nursing home patients with dementia. Psychiatry Res 48: 277-292.
9. Bliwise DL. 1994. What is sundowning? J Am Geriatr Soc 42: 1009-1011.
10. Cohen-Mansfield J, Werner P, Marx MS, Freedman L. 1991. Two studies of pacing in the nursing home. J Gerontol 46: M77-83.
11. Colon-Emeric CS, Biggs DP, Schenck AP, Lyles KW. 2003. Risk factors for hip fracture in skilled nursing facilities: who should be evaluated? Osteoporos Int 14: 484-489.
12. Folstein MF, Folstein SE, McHugh PR. 1975. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
13. Games PA. 1977. An improved t table for simultaneous control on g contrasts. J Am Star Assoc 72: 531-534.
14. Kavcic V, Duffy CJ. 2003. Attentional dynamics and visual perception: mechanisms of spatial disorientation in Alzheimer's disease. Brain 126: 1173-1181.
15. Klein DA, Steinberg M, Galik E, et al. 1999. Wandering behaviour in community-residing persons with dementia. Int J Geriatr Psychiatry 14: 272-279.
16. Lawton MP, Brody EM. 1969. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: 179-186.
17. Lyketsos CG, Steele C, Baker L, et al. 1997. Major and minor depression in Alzheimer disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 9: 556-561.
18. Martino-Saltzman D, Blasch BB, Morris RD, McNeal LW. 1991. Travel behavior of nursing home residents perceived as wanderers and nonwanderers. Gerontologist 31: 666-672.
19. Meguro K, Yamaguchi S, Itoh M, et al. 1997. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study. Neurology 49: 941-945.
20. Norman GR, Streiner DL. 2000. Biostatistics: The Bare Essentials. BC Decker Inc.: Hamilton, Ontario.
21. Ohayon MM, Roth T. 2002. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53: 547-554.
22. Pinninti NR, Mago R, Townsend J, Doghraniji K. 2005. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol 25: 617-618.
23. Rabins PV, Mace NL, Lucas MJ. 1982. The impact of dementia on the family. JAMA 248: 333-335.
24. Rolland Y Payoux P, Lauwers-Cances V, et al. 2005. A SPECT study of wandering behavior in Alzheimer's disease. Int J Geriatr Psychiatry 20: 816-820.
25. Rowe MA, Glover JC. 2001. Antecedents, descriptions, and consequences of wandering in cognitively-impaired adults and the Safe Return (SR) program. Am J Alzheimers Dis Other Demen 16: 344-352.
26. Sanford JR. 1975. Tolerance of debility in elderly dependants by supporters at home: its significance for hospital practice. Br Med J 3: 471-473.
27. Sheikh JI, Yesavage JA. 1986. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 5: 165-173.
28. Shyu YI, Yip PK, Chen RC. 1996. Caregiving experiences of family caregivers of elderly persons with dementia in northern Taiwan. Kaohsiung J Medl Sci 12: 50-61.
29. Silverstein NM, Flaherty G, Tobin TS. 2002. Dementia and Wandering Behavior. Concern for the Lost Elder. Springer Publishing Company: New York.
30. Song JA, Algase DL, Beattie ER, et al. 2003. Comparison of US, Canadian, and Australian participants' performance on the Algase Wandering Scale-Version 2 (AWS-V2). Res Theory Nurs Pract 17: 241-256.
31. Tanaka Y, Meguro V, Yamaguchi S, et al. 2003. Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease. Ann Nucl Med 17: 567-573.
32. Tetewsky SJ, Duffy CJ. 1999. Visual loss and getting lost in Alzheimer's disease. Neurology 52: 958-965.
33. Thomas DW. 1997. Understanding the wandering patient: a continuity of personality perspective. J Gerontol Nurs 23: 16-24.
34. Turjanski N, Lees AJ, Brooks DJ. 1999. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52: 932-937.
35. Volicer L, Harper DG, Manning BC, et al. 2001. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158: 704-711.
36. Wetter TC, Brunner J, Bronisch T. 2002. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 35: 109-111.
37. Yang C, White DP, Winkelman JW. 2005. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 58: 510-514.